Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
484.24
+3.91 (0.81%)
At close: Feb 21, 2025, 4:00 PM
489.00
+4.76 (0.98%)
After-hours: Feb 21, 2025, 4:47 PM EST
Vertex Pharmaceuticals Revenue by Segment
History
| Date | Trikafta and Kaftrio | Kalydeco | Orkambi | Symdeko and Semkevi |
|---|---|---|---|---|
| Dec 31, 2024 | 10.19B | - | - | - |
| Sep 30, 2024 | 9.81B | - | - | - |
| Jun 30, 2024 | 9.50B | - | - | - |
| Mar 31, 2024 | 9.29B | - | - | - |
| Dec 31, 2023 | 8.94B | 475.50M | 326.00M | 123.00M |
| Sep 30, 2023 | 8.63B | 499.20M | 392.60M | 129.50M |
| Jun 30, 2023 | 8.37B | 525.80M | 475.80M | 134.30M |
| Mar 31, 2023 | 8.02B | 539.20M | 501.10M | 145.80M |
| Dec 31, 2022 | 7.69B | 553.20M | 510.70M | 180.00M |
| Sep 30, 2022 | 7.36B | 569.30M | 547.30M | 226.10M |
| Jun 30, 2022 | 6.90B | 592.30M | 585.60M | 269.30M |
| Mar 31, 2022 | 6.27B | 636.90M | 685.00M | 360.10M |
| Dec 31, 2021 | 5.70B | 684.20M | 771.60M | 420.40M |
| Sep 30, 2021 | 5.10B | 725.40M | 839.66M | 467.53M |
| Jun 30, 2021 | 4.50B | 756.86M | 881.08M | 542.31M |
| Mar 31, 2021 | 4.16B | 776.62M | 892.06M | 580.54M |
| Dec 31, 2020 | 3.86B | 802.90M | 907.50M | 628.60M |
| Sep 30, 2020 | 3.19B | 845.08M | 1.12B | 832.91M |
| Jun 30, 2020 | 2.23B | 900.62M | 1.19B | 1.08B |
| Mar 31, 2020 | 1.32B | 959.67M | 1.27B | 1.27B |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.